Age-related alterations in T-lymphocytes modulate key pathways in prostate tumorigenesis

Prostate

Volumn 73, Issue 8, 2013, Pages 855-864

  De Angulo, Alejandra ^a   Faris, Robert ^a   Cavazos, David ^a   Jolly, Christopher ^a   Daniel, Benajmin ^b   Degraffenried, Linda ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

aging; immune system; inflammation; NF B

Indexed keywords

ACTIN; CYCLIN D; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN BCL XL;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; WESTERN BLOTTING; WILD TYPE;

AGING; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; IMMUNOASSAY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROSTATIC NEOPLASMS; T-LYMPHOCYTES;

EID: 84876950635     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22631     Document Type: Article

References (30)

1. Gann PH,. Risk factors for prostate cancer. Rev Urol 2002; 4 (Suppl 5): S3-S10.
2. Leitzmann MF, Rohrmann S,. Risk factors for the onset of prostatic cancer: Age, location, and behavioral correlates. Clin Epidemio 2012; 4: 1-11.
3. Jolly CA, Xu Z,. Models of immune function in aging. In:, Conn PM, editor. Handbook of models for human aging. Burlington, MA: Elsevier Academic Press; 2006. pp 771-779.
4. Collison LW, Murphy EJ, Jolly CA,. Glycerol-3-phosphate acyltransferase1 regulate murine T-lymphocyte proliferation and cytokine production. Am J Physiol Cell Physiol 2008; 295 (6): C1543-C1549.
5. Collison LW, Kannan L, Onorato TM, Knudsen J, Haldar D, Jolly CA,. Aging reduces glycerol-3-phosphate acyltransferase activity in activated rat splenic T-lymphocytes. Biochim Biophys Acta 2005; 1687 (1-3): 164-172.
6. Kannan L, Knudsen J, Jolly CA,. Aging and acyl-CoA binding protein alter mitochondrial glycerol-3-phosphate acyltransferase activity. Biochim Biophys Acta 2003; 1631 (1): 6-12.
7. Collison LW, Jolly CA,. Phosphorylation regulates mitochondrial glycerol-3-phosphate-1 acyltransferase activity in T-lymphocytes. Biochim Biophys Acta 2006; 1761 (1): 129-139.
8. Brüünsgaard H, Pedersen BK,. Age-related inflammatory cytokines and disease source department of infectious diseases immunol allergy. Clin North Am 2003;(1): 15-39.
9. Dolcet X, Llobet D, Pallares J, Matias-Guiu X,. NF-kB in development and progression of human cancer. Virchows Archiv 2005; 446 (5): 475-482.
10. Tak PP, Firestein GS,. NF-kB: A key role in inflammatory diseases. J Clin Invest 2011; 10 (1): 7-11.
11. Baldwin AS,. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107 (3): 241-246.
12. Cavazos DA, Price RS, Apte S, deGraffenried LA,. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. Prostate 2011; 71 (13): 1420-1428.
13. Karin M,. NF-kappaB and cancer: Mechanisms and targets. Mol Carcinog 2006; 45 (6): 355-361.
14. Karin M, Cao Y, Greten FR, Li ZW,. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002; 2 (4): 301-310.
15. Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL,. NF-kappaB regulates androgen receptor expression and prostate cancer growth. Am J Pathol 2009; 175 (2): 489-499.
16. Karin M, Ben-Neriah Y,. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-663.
17. Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Nishimura Y, Imamura M,. Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer 1999; 35: 1374-1380.
18. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS,. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999; 19: 5785-5799.
19. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M,. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 1999; 19: 2690-2698.
20. Yu Q, Geng Y, Sicinski P,. Specific protection against breast cancers by cyclin D1 ablation. Nature 2011; 411: 1017-1021.
21. Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar D,. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 2000; 42: 73-78.
22. Yatani R, Chigusa I, Akazaki K,. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982; 29: 611-616.
23. Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT,. Prostate carcinoma presentation, diagnosis, and staging: An update from the National Cancer Data Base. Cancer 2003; 98 (6): 1169-1178.
24. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG,. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 4: 256-269.
25. Shukla S, MacLennan GT, Marengo SR, Resnick MI, Gupta S,. Constitutive activation of PI3K-Akt and NF-κB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005; 64: 224-239.
26. Bonizzi G, Karin M,. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-288.
27. Zhang Q, Liu S, Ge D, Zhang Q, Xue Y, Xiong Z, Abdel-Mageed AB, Myers L, Hill SM, Rowan BG, Sartor O, Melamed J, Chen Z, You Z,. Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res 2012; 72 (10): 2589-2599.
28. Abajo A, Bitarte N, Zarate R, Boni V, Lopez I, Gonzalez-Huarriz M, Rodriguez J, Bandres E, Garcia-Foncillas J,. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. World J Gastroenterol 2012; 18 (7): 637-645.
29. Vaday GG, Peehl DM, Kadam PA, Lawrence DM,. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 2006; 66 (2): 124-134.
30. Sfanos KS, De Marzo AM,. Prostate cancer and inflammation: The evidence. Histopathology 2012; 60 (1): 199-215.